Ovarian Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with a likely or confirmed new or returning cancer tumour of any stage.
- People who are planned to receive chemotherapy or combined chemotherapy and radiation treatment before surgery (known as neoadjuvant treatment).
- People who have been assessed as suitable candidates for one of the following operations: removal of part or all of the pancreas, removal of part or all of the stomach, removal of part of the oesophagus (food pipe), removal of the bladder, removal of the lower part of the large bowel (with the bowel reconnected), removal of the lower bowel and back passage, or a procedure to remove tumours in the abdomen combined with heated chemotherapy delivered directly into the abdominal cavity.
- People aged over 18 years.
- People who have a general health and activity level rated between 0 and 2 on a standard scale used by doctors to measure how cancer affects daily functioning (confirm with trial site).
- People who are able to understand and are willing to sign a written consent form and a related privacy authorisation document.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are unable to complete the study requirements, such as attending at least two visits for each type of specialist referral involved in the study.
- People who do not go on to have their surgery at an institution connected to this trial.
- People who are pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Stephanie Gzreco, MD, Fox Chase Cancer Center
Phone: 2152143719
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
30-Day Rate of Death or Serious Complications After Surgery
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.